Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: The role of CagA status

American Journal of Gastroenterology

Volumn 93, Issue 3, 1998, Pages 375-379

  Sozzi, Michele ^a   Valentini, M ^b   Figura, N ^b   De Paoli, P ^b   Tedeschi, R M ^b   Gloghini, A ^b   Serraino, D ^b   Poletti, M ^b   Carbone, A ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; DISEASE ASSOCIATION; DISEASE MARKER; ENDOSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STOMACH ADENOCARCINOMA;

ADULT; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOPSY; FEMALE; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; MIDDLE AGED;

EID: 0032034097     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00375.x     Document Type: Article

References (44)

1. 1. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. Br Med J 1991;302:1302-5.
2. 2. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325: 1127-31.
3. 3. Nomura A, Stemmermann GN, Chyou P, et al. Helicobacter pylori infection and gastric carcinoma in a population of Japanese-Americans in Hawaii. N Engl J Med 1991;325:1132-6.
4. 4. EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-62.
5. 5. Blaser MJ, Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994;94:6-8.
6. 6. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infections. Epidemiol Rev 1991;13:42-59.
7. 7. Akopyanz N, Bukanov NO, Westblom TU, et al. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res. 1992;20:5137-5142.
8. 8. Fujimoto S, Marshall B, Blaser MJ. PCR-based restriction fragment length polymorphism typing of Helicobacter pylori. J Clin Microbiol 1994;32:331-4.
9. 9. Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high molecular weight major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production. Infect Immunol 1993;61:1799-1809.
10. 10. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993;90:5791-5.
11. 11. Xiang Z, Censini S, Bayeli PF, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995;63:94-8.
12. 12. Crabtree JE, Covacci A, Farmery SM, et al. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol 1995;48:41-5.
13. 13. Crabtree JE, Farmery SM, Lindley IJ, et al. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994;47:945-50.
14. 14. Censini S, Lange C, Xiang Z, et al. cag, A pathogenicity island of Helicobacter pylori, encodes type I-specific and diseases-associated virulence factors. Proc Natl Acad Si USA 1996;93:14648-53.
15. 15. Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991;338:332-5.
16. 16. Oderda G, Figura N, Bayeli PF, et al. Serologic IgG recognition of Helicobacter pylori cytotoxin-associated protein, peptic ulcer and gastroduodenal pathology in childhood. Eur J Gastroenterol Hepatol 1993; 5:695-9.
17. 17. Cover TL, Dooley CP, Blaser MJ. Characterization of human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990;58:603-10.
18. 18. Blaser MJ, Péréz-Péréz GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Research 1995;55:2111-5.
19. 19. Correa P. Human gastric carcinogenesis: A multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-40.
20. 20. Price AB. The Sydney system: Histological division. J Gastroenterol Hepatol 1991;6:209-22.
21. 21. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. Am J Surg Pathol 1996;20:1161-81.
22. 22. Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Scientific Publications, 1987:93-140.
23. 23. Fontham ETH, Ruiz B, Perez A, et al. Determinants of Helicobacter pylori infection and chronic gastritis. Am J Gastroenterol 1995;90: 1094-101.
24. 24. Kuipers EJ, Uyterlinde M, Pena AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
25. 25. Rugge M, Cassaro M, Leandro G, et al. Helicobacter pylori in promotion of gastric carcinogenesis. Dig Dis Sci 1996;41:950-5.
26. 26. Kuipers EJ, Pérez-Pérez GI, Meuwissen GM, et al. Helicobacter pylori and atrophic gastritis: Importance of the cagA status. J Natl Cancer Inst 1995;87:1777-80.
27. 27. Correa P, Yardley JH. Grading and classification of chronic gastritis: One American response to the Sydney system (see comment citations in Medline). Gastroenterology 1992;102:355-9.
28. 28. Sipponen P, Kekki M, Siural M. The Sydney system: Epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol 1991; 6:244-51.
29. 29. Stolte M, Eidt S, Ohnsmann A. Differences in Helicobacter pylori associated gastritis in the antrum and body of the stomach. Z Gastroenterol 1990;28:229-33.
30. 30. Fox JG, Correa P, Taylor NS, et al. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol 1992;87:1554-60.
31. 31. Beales LP, Crabtree JE, Scunes D, et al. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Eur J Gastroenterol 1996;8:645-9.
32. 32. Peek RM, Miller GG, Tham KT, et al. Detection of cagA expression in vivo and demonstration of preferential cytokine expression by cagA+ H. pylori strains in gastric mucosa. Am J Gastroenterol 1994; 89:1344.
33. 33. Peek RM, Miller GG, Tham KT, et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 1996;71:760-70.
34. 34. Graham DY, Genta RM, Graham DP, et al. Scrum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: Lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol 1996;49:829-32.
35. 35. Xiang Z, Bugnoli M, Ponzetto A, et al. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1993;12:739-45.
36. 36. Sipponen P, Riihela M, Hyvarinen H, et al. Chronic non-atrophic "superficial" gastritis raises the risk of gastric cancer. Scand J Gastroenterol 1994;29:336-40.
37. 37. Sipponen P. Gastric cancer: A long-term consequence of Helicobacter pylori infection? Scand J Gastroenterol 1994;29:24-7.
38. 38. Correa P, Haenszel W, Cuello C, et al. The gastric precancerous process in a high risk population: Cross-sectional studies. Cancer Res 1990;50:4731-6.
39. 39. Cheli R, Simon L, Aste H, et al. Atrophic gastritis and intestinal metaplasia in asymptomatic Hungarian and Italian populations. Endoscopy 1980;12:105-8.
40. 40. Ihamäki T, Varis K, Siurala M. Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families: Comparison with a computer-matched family sample. Scand J Gastroenterol 1979;14:801-12.
41. 41. Sitas F, Smallwood R, Jewell D, et al. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis. Cancer Epidemiol, Biomarkers & Prev 1993; 2:119-23.
42. 42. Muñoz N, Kato I, Peraza S, et al. Prevalence of precancerous lesions of the stomach in Venezuela, Cancer Epidemiol, Biomarkers & Prev 1996;5:41-6.
43. 43. Genta RM. Helicobacter pylori as a promoter of intestinal metaplasia and gastric cancer: An alluring hypothesis in search of evidence. Eur J Gastroenterol & Hepatol 1995;7:S25-30.
44. 44. Kawaguchi H, Haruma K, Komoto K, et al. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol 1996;91:959-62.